News

Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil

News

Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum

News

Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta

News

After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct

News

Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds

Research Fellow Works with ACTH

NO WRITER ATTRIBUTED

A University research fellow is working with ACTH, the miracle pituitary hormone used to treat arthritis. Martin G. Ettlinger research fellow in Chemistry, said yesterday that his work may be a first step in producing ACTH at a far lower cost than its present $100-a-gram price.

Ettlinger is trying to isolate the ACTH hormone in its pure form. "If this research is successful," he said, "it may lead to the production of a synthetic ACTH which will be available to many more persons than the present product which is extracted from the pituitary glands of hogs."

Ettlinger is working under a grant from the American Cyanamid Company with Dr. Edwin B. Astwood, professor of Research Medicine at Tufts.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags